Abstract 33
cases aged 5-14 and 15+ years old additionally providing Health-Related Quality of Life (HR-48
QoL) loss estimates through completing EQ-5D-3L-Y and EQ-5D-3L instruments respectively. 49
The questionnaire responses from the suspected cases were used to calibrate the regression 50 model. The calibrated regression model then used other questionnaire responses to predict the 51 HR-QoL loss without the use of EQ-5D instruments. The age-specific QALY loss was then 52 calculated by multiplying the HR-QoL loss on the worst day predicted from the regression 53 model, with estimates for the duration of infection from the questionnaires and a scaling 54 factoring for disease severity. Our regression model for predicting HR-QoL loss estimates that 55 for the worst day of infection, suspected RSV cases in persons five years and older who do and 56 do not seek healthcare have an HR-QoL loss of 0·616 (95% CI 0·155-1·371) and 0·405 (95% 57 CI 0·111-1·137) respectively. This leads to a QALY loss per RSV episode of 1·950 × 10 -3 (95% 58 CI 0·185 × 10 -3 -9·578 × 10 -3 ) and 1·543 × 10 -3 (95% CI 0·136 × 10 -3 -6·406 × 10 -3 ) respectively. 59
For confirmed cases in a child under the age of five years who sought healthcare, our model 60 predicted a HR-QoL loss on the worst day of infection of 0·820 (95% CI 0·222-1·450) resulting 61 in a QALY loss per RSV episode of 3·823 × 10 -3 (95% CI 0·492 × 10 -3 -12·766 × 10 -3 ). Combing 62
Regression model 156
EQ-5D instruments are not validated for children under five years of age so we cannot obtain 157 estimates for the raw maximum HR-QoL loss in the confirmed cases. Therefore, using the 158 responses from the suspected cases, we used a mixture model approach to estimate the 159 maximum HR-QoL loss as a function the independent variables-age (5-14 years, 15 years 160 and older), coughing severity, healthcare seeking behaviour, productivity and VAS score loss. 161 We classified the adjusted maximum HR-QoL loss for each RSV episode as either severe 162
(above a threshold value h) or mild (equal to or below h), with probability p and 1-p respectively. 163
For suspected cases with a raw maximum HR-QoL loss above h, we used a linear regression 164 model to estimate the adjusted maximum HR-QoL loss in severe episodes as a function of the 165 independent variables. Similarly, for suspected cases with a raw maximum HR-QoL loss equal 166 to or below h, we used a log-transformed linear regression model to estimate the adjusted 167 maximum HR-QoL loss in mild episodes as a function of the independent variables. The raw 168 maximum HR-QoL loss values were log-transformed to prevent negative adjusted maximum 169 HR-QoL loss values. Finally, by transforming the raw maximum HR-QoL loss to a binary 170 variable-0 for mild infections and 1 for severe infection-we used a logistic regression to 171 calculate the probability of a severe episode p as a function of the independent variables. 172
7
The final three regression models contain those variables that significantly influenced the 174 adjusted maximum HR-QoL at the 5% significant level (Appendix II). The variance of the full 175 mixture model was estimated by simulation using prediction intervals for the linear and log-176 transform linear model and confidence intervals for the logistic regression model. The threshold 177 value h was estimated by finding the minima of the fitted mixture distribution for the raw 178 maximum HR-QoL loss values. To assess the accuracy of the model, we compared the 179 distributions derived from between the raw and adjusted maximum HR-QoL loss for the 180 suspected cases for each of the independent variables considered in the model calibration. The 181 regression analysis, hypothesis testing for significant covariates, and stochastic simulation was 182 performed in R (v. 3.3.2), and plotting was performed in Mathematica (v. 10.3.0.0). 183 184 Quality-adjusted life year (QALY) loss due to an RSV episode 185
For confirmed cases in children under the age of five years and suspected cases in persons 186 aged five years and older, we estimated each respondent's QALY loss by multiplying the 187 adjusted maximum HR-QoL life loss by the duration of coughing and a scaling factor for disease 188 severity throughout this duration. We estimated the distribution of coughing duration for 189 confirmed and suspected cases separately by pooling responses, respectively (Appendix II). We 190 estimated the scaling factor for disease severity using detailed data from the Flu Watch study, were also asked to complete daily EQ-5D instruments during each day of illness. These five 195 sets of responses resulted in daily HR-QoL estimates from five community cases of confirmed 196 RSV (ages 16-45), from which we quantified five estimates of the scaling factor of disease 197 severity as the average daily severity of the symptoms relative to the maximum HR-QoL loss. 198
We then took the mean of these values to estimate the scaling factor for disease severity. It is 199 not possible to obtain estimates for the QALY loss in confirmed infections who are under the 200 age of five years who did not seek healthcare as the confirmed cases were recruited into the 201 study conditional on them seeking healthcare. Therefore, to gain QALY loss estimates we 202 assume that the ratio of QALY loss for people over five years who seek healthcare to those that 203 do not is the same independent of age. (Table 1) . Further, we found that 252 17/33 (51·5%) children aged 5-14 years old took time off school and 9/54 (16·6%) of persons 253 aged 15 years and older took time off work or school due to their suspected RSV infection, both 254 with a median time off of 2 days (range 1-10) ( Table 1) . The EQ-5D-Y instruments suggested 255 that for children aged 5-14 years old the dimensions of healthcare which were most affected by 256 RSV were the effect on usual activities (72%), pain/discomfort (76%) and anxiety/depression 257 (84%). The EQ-5D-3L responses for respondents aged 15 years and older suggested similar 258 results with RSV affecting respondents' usual activities (54·2%), causing pain/discomfort 259 (36·0%) and anxiety and depression (32·0%) (Figure 2) . After using the UK TTO scoring tariff, 260 the raw HR-QoL weight for the worst day of infection for children aged 5-14 years old and 261 persons 15 years and older was 0·630 (range -0·429-1·000) and 0·630 (range -0·429-1·000) 262 respectively. (Table S7) . This led to a raw maximum HR-QoL loss of 0·456 (range 0·0-1·170) 263 and 0·358 (range 0-0·998) for 5-14 and 15 years and older respectively. As there was no 264 significant difference between the raw maximum HR-QoL loss between 5-14 years old and 265 persons 15 years (Kolmogorov-Smirnov test, p = 0·291), all HR-QoL and QALY results were 266 pooled for further analysis. 267
268
Adjusted maximum HR-QoL loss 269
We found the threshold value for the maximum HR-QoL loss, above which infections are 270 considered severe, to be h = 0·582 (Figure S1 ). Using linear regression, we found that VAS 271 score loss significantly adjusted the adjusted maximum HR-QoL loss for mild infections (p < 272 0·001), and healthcare-seeking behaviour (none or any) for severe infection (p = 0·0012). Using 273 logistic regression, we found that coughing severity (none/mild or severe) significantly adjusted 274 the probability of severe infections (p < 0·001) ( Table S2 and Figures S3-S6) . 275 276 Our full mixture model estimated the adjusted maximum HR-QoL loss in suspected cases aged 277 five years and older who did and did not seek health care as 0·616 (95% CI 0·155-1·371) and 278 0·405 (95% CI 0·111-1·137) respectively. We used the calibrated mixture model to estimate the 279 adjusted maximum HR-QoL loss for confirmed cases less than five years of age, who sought 280 health care as 0·820 (95% CI 0·222-1·450). In assessing the model accuracy, we found the 281 difference between the means of the HR-QoL loss between the raw and adjusted maximum HR-282
QoL loss for each of the independent variables was 0·063 (range 0·026-0·154) (Figure 3) . 283 Similarly, for children under five years, the estimated number of both GP consultations and 305 hospital admissions due to RSV in the UK is 369,302 (range 253,825-467,277). 15 Using our 306 estimate of 3·823 × 10 -3 for the QALY loss for healthcare seeking episodes in children under the 307 age of five years, this results in a mean annual QALY loss of 1,411 (range 970-1786). These 308 results suggest that 45·9% of the annual QALY loss due to RSV episodes seeking healthcare is 309 attributable to persons five years and older. 310 311 Further, using our result that 25% of individuals aged five years and older seek healthcare, we 312 estimate that there are approximately 1.8 (range 1.6-3.0) million RSV infections in the UK 313 annually that will not be captured in a healthcare-focussed surveillance system. The mean 314 annual QALY loss associated with these non-surveilled episodes for persons five years and 315 older is around 2,900 (range 2,460-4,706), suggesting that approximately 29% of the QALY 316 loss in this age group can only be captured by community surveillance. 317
Discussion 318
In this study, we quantified the quality of life (QALY) loss associated with RSV episodes. For 319 children over five years old and adults, we found that the QALY loss can be accurately predicted 320 by whether there was severe coughing, whether healthcare was sought, and Visual Analogue 321 Scale score loss. We used a novel statistical model to evaluate the QALY loss in children under 322 five years old, in whom the majority of severe RSV episodes occur. We found the QALY loss in 323 children under the age of five years who sought healthcare is 3·823 × 10 -3 (95% CI 0·492-324 12·766), and for persons five years and older to be 1·950 × 10 -3 (95% CI 0·185-9.578) for those 325 who seek healthcare and 1·543 × 10 -3 (95% CI 0·136-6·406) and for those who do not seek 326
healthcare. In addition, we found the 73·6% of infections in persons over the age of five did not 327 seek healthcare, and 30·0% took time off due to their infection. 328
329
Our study has some limitations. First, because the confirmed cases were recruited into the 330 study conditional on them seeking healthcare, we could not estimate the QALY loss in children 331 less than five years old who did not seek healthcare. To overcome this limitation, we assume 332 that the ratio of QALY loss for people over five years who seek healthcare to those that do not is 333 the same independent of age. To collect data directly on the QALY loss in children under five 334 who do not seek healthcare would require a much larger and more intensive community-based 335 study with frequent testing throughout an RSV season. Second, suspected cases may have 336 experienced non-RSV respiratory disease. However, as previous studies have shown that 337 around 70% of households experience a second infection in either siblings or parents during the 338 same time as an infant, we think it is reasonable to assume that the majority of suspected cases 339 are in fact RSV. 17, 18 Finally, completing questionnaires some days after symptoms may be 340 subject to recall bias as our estimates for the maximum HR-QoL life loss for persons aged 15 341 years and older (0.452 (95% CI 0.177-1.222)) are larger to the maximum HR-QoL loss 342 estimated during the infection in the Flu Watch study (range 0.107-0.309). 343
344
Our study is the first to estimate the QALY loss due to acute RSV infection across all ages. In 345 addition, we developed a novel method to estimate QALY loss due to RSV in young children for 346 whom standardised instruments for deriving HR-QoL estimates are not appropriate. Thus our 347 method leverages the use of standardised instruments such as EQ-5D to quantify QALY loss 348 using more easily measurable variables of infection in young children. In particular, we derived a 349 method for determining the maximum HR-QoL loss due to RSV infection. We found two 350 previous studies which also estimated the HR-QoL due to RSV infection both of which suffer 351 13 from shortcomings. The first is a Time Trade-off study which derived HR-QoL life estimates 352 using responses from participants about a hypothetical illness that they, or their child, had not 353 experienced.
19,20 Our study is advantageous because the adjusted maximum HR-QOL loss 354 values are the subjective HR-QoL estimates from people who have, or suspected to have 355 experienced an RSV infection. The second study estimates the HR-QoL using EQ-5D 356 instruments, however the results are derived by describing the current condition of a five-year-357 old child with a history of RSV-it is not a health utility for an RSV episode. Therefore, this 358 estimate is for RSV sequelae, which can complement our estimate for RSV infections derived in 359 this study. Despite the limitations in this study, it is the primary source of HR-QoL estimates for 360 existing RSV cost-effectiveness analysis.
19 Using HR-QoL loss for RSV sequelae of acute RSV 361 infection in cost-effectiveness analysis could underestimate the impact of potential intervention 362 strategies. We recommend that future cost-effectiveness analyses additionally use directly 363 obtained HR-QoL loss estimates for RSV episodes, such as those presented in this paper, to 364 ensure that the cost-effectiveness of potential intervention programmes is accurately 365 determined. 366
367
We compared the adjusted maximum HR-QoL loss found in the novel statistical model with the 368 raw maximum HR-QoL loss for independent variables used to calibrate the transmission model 369 to assess the model accuracy. We found that the difference between the means of the two 370 methods of calculating the maximum HR-QoL was less than 0·1 HR-QoL loss for 66% of the 371 independent variables considered, implying that the model predicts with accuracy. 372
373
We estimated a QALY loss of 1·758 × 10 -3 (95% CI 0·150-7·303 × 10 -3 ) due to a suspected 374 RSV episode in persons aged five years and older. Comparing our study to the Flu Watch 375 prospective cohort study, we found that the QALY loss for an RSV episode is less than the 376 QALY loss for a confirmed Influenza H1N1 episode, which is estimated to have mean 4·4 × 10 -3 377 (range -2·5-18·2 × 10 -3 ) across all ages. 22 However, our estimates are similar to the QALY loss 378 for cases of respiratory disease in the same study which were not confirmed to be Influenza, but 379 were confirmed to suffer from a fever and reported coughing/sore throat (mean 2·6 × 10 -3 (range 380 -69·2-39·7 × 10 -3 ) across all ages). We cannot compare the QALY loss due to the confirmed 381 RSV episodes in children under the age of five (3·823 × 10 -3 (95% CI 0·492-12·766 × 10 -3 )), 382 with values from the Flu Watch because the confirmed RSV infections were recruited dependent 383 on an infection being severe and requiring medical attention. We therefore compare estimates 384 to a different study which suggests that these RSV severe episodes are milder than hospitalised 385 Influenza episodes, (QALY loss of 6·0 × 10 -3 (range 5·1-6·9 × 10 -3 )) but similar in severity to 386 non-Influenza episodes who suffer Influenza-like illness (ILI) and present at a clinical interface 387 (4·0 × 10 -3 (range 3·4-4·6 × 10 -3 )). 23 These comparisons suggest that, though Influenza has a 388 higher QALY loss per episode, the QALY loss due to an RSV episode is comparable to previous 389 QALY loss estimates for persons with general ILI. In a wider context, comparing with QALY 390 estimates derived via EQ-5D instruments with UK TTO scoring tariff for measles, another 391 disease with high burden in children, the QALY loss was 0·019 (95% CI 0·016-0·022) per 392 episode. We estimated that 46% of the QALY loss associated with healthcare seeking episodes was 395 attributable to individuals five years and older. This result suggests that neglecting QALY loss in 396 older children and working age adults might substantially underestimate the impact of a 397 potential RSV vaccine programme. Further, RSV is characterised by high levels of household 398 transmission, 25,26 which points to a need to evaluate both the direct and herd protection effects 399 of potential vaccination strategies into impact assessments. Together, this evidence suggests 400 that integrating transmission models into economic evaluations will be important to accurately 401 estimate the impact of potential vaccine programmes across the entire population. 402
403
In this study we are only able to directly estimate the QALY loss for children under five years old 404 who do not seek healthcare, we cannot evaluate the frequency at which this occurs. However, 405
we expect the probability of healthcare seeking in children under the age of five years to be 406 higher than the 25% reported in those aged five years and older for two reasons: because 407 infections in infants are generally more severe, with higher rates of symptomatic infections, 27 408 and because of possible increased parental healthcare seeking for infants. 28 Regardless, the 409 healthcare seeking behaviour for both children and adults will likely depend on the region and 410 careful consideration will need to be taken into account in economic evaluations. 411
412
In summary, we estimated the QALY loss due to an RSV episode in confirmed cases in children 413 less than five years old and suspected cases in persons five years old or older. The QALY loss 414 due to an RSV episode is less than the QALY loss due to an influenza episode. In addition, RSV 415 infections in individuals aged five years and older account for 46% of the annual QALY loss 416 attributable to healthcare seeking episodes in the UK. Consequently, economic evaluations of 417 potential vaccine programmes should consider the effect on reducing incidence not only where 418 the severe disease burden lies, but across the across the whole population. 
